ATYR
aTyr Pharma
ATYR
ATYR
56 hedge funds and large institutions have $81.5M invested in aTyr Pharma in 2024 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
22% more funds holding
Funds holding: 46 → 56 (+10)
8.73% less ownership
Funds ownership: 70.43% → 61.71% (-8.7%)
Holders
56
Holding in Top 10
–
Calls
$15K
Puts
$8K
Top Buyers
| 1 | +$3.28M | |
| 2 | +$1.36M | |
| 3 | +$1.17M | |
| 4 |
Barclays
London,
United Kingdom
|
+$1.02M |
| 5 |
Renaissance Technologies
New York
|
+$770K |
Top Sellers
| 1 | -$5.36M | |
| 2 | -$1.85M | |
| 3 | -$680K | |
| 4 |
PFCS
Pale Fire Capital SE
Prague,
Czech Republic
|
-$395K |
| 5 |
Squarepoint
New York
|
-$168K |